EDEM2 and breast carcinoma: In total, 19 of these have been associated with multiple malignancies including breast cancer, based on the current literature, but no direct evidence exists though to link the remaining two of the 21 markers (EDEM2 and IL18BP) to breast cancer, making these the most promising novel breast cancer markers identified here.